UBS Maintains Buy Rating On Pfizer Inc. (PFE)
Benzinga - 55 minutes ago
Analysts Marc Goodman and Ami Fadia at UBS have released an update on Pfizer Inc. (NYSE: PFE). UBS recently attended an investor dinner with Pfizer's CFO and IR. The key takeaways from the meeting ...
http://bit.ly/9srxea
No comments:
Post a Comment